Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-11-14-Speech-3-026"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-11-14"^^xsd:date2
dcterms:Is Part Of	lp_eu:European Research Area (Multiannual Framework Programme 2002-2006)2
dcterms:Language	"el"^^xsd:language2
lpv:document identification number	"en.20011114.2.3-026"2
lpv:hasSubsequent	lp_eu:2001-11-14-Speech-3-0272
lpv:speaker	lp:Antonios Trakatellis2
lpv:spokenAs	substitute; Committee on Industry, External Trade, Research and Energy (1999-07-21--2002-01-14)3 member_of_the_bureau; EPP-ED (2000-04-10--2004-07-19)3 substitute; Delegation to the EU-Cyprus Joint Parliamentary Committee (1999-10-08--2002-01-14)3 member; Delegation for relations with Israel (1999-10-06--2002-01-14)3 vice-chair; Temporary committee on human genetics and other new technologies in modern medicine (2001-01-16--2001-11-29)3 unknown; Nea Dimokratia (1999-07-20--2004-07-19)3 member; Committee on the Environment, Public Health and Consumer Policy (1999-07-21--2002-01-14)3
lpv:translated text	"Mr President, the European Union's Sixth Framework Programme covers high-priority areas and areas of pioneering research from which we expect quantum leaps in science. I should like to draw your attention to the pioneering area of research into the human genome. This research is expected to have future applications in four areas of medicine: first, hereditary illnesses, secondly, the most common fatal illnesses, namely cancer, cardio-vascular and degenerative neural illnesses, thirdly, an understanding of the mechanics of various illnesses, which will lead to new, more efficient treatment and drugs and, fourthly, the prevention of disease. New knowledge about human genetics will help us understand at which points genetic dynamics are vulnerable and open to environmental factors and pressure and the way in which we live, thereby allowing us to develop new strategies for the prevention, diagnosis and treatment of the illnesses which I have already mentioned. Stem cell research may well have new applications in treating illnesses such as Parkinson's disease, Alzheimer's, leukaemia and many others. However, the boundaries on research in these fields must be marked out if we are to avoid ethical problems. This was the point of the amendment which I tabled together with Mr Nisticò and Mr Purvis. This amendment will allow the pioneering research which I have described to progress while striking the balance needed in order to avoid ethical problems. So we can look forward to the beneficial medical applications which this research promises. I trust that the European Parliament will support the line being marked out and strike the right balance between progress and ethical considerations."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph